Major depressive disorder (MDD) is one of the leading causes of disability worldwide, and approximately 30% of patients ...
Major depressive disorder (MDD) is one of the leading causes of disability worldwide, and approximately 30% of patients ...
A new brain-imaging study has revealed how ketamine produces its fast antidepressant effects in people with ...
This framework was applied to neural recordings from animals receiving one of the three anesthetics—propofol, ketamine, and dexmedetomidine.
When patients undergo general anesthesia, doctors can choose among several drugs. Although each of these drugs acts on ...
Researchers used a novel PET tracer to visualize how ketamine alters AMPA receptor distribution in the brains of patients ...
The 7 mg dose of OV329 demonstrated favorable safety and tolerability profile, reinforcing best-in-category potential for ...
Major depressive disorder (MDD) is a major global health problem and one of the leading causes of disability. About 30% of people diagnosed with ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results